FLGT News and Press, Fulgent Genetics Inc. From 01/05/21

Fulgent's core genetic testing business is recovering and should improve even further due to synergies with the COVID-19 business. Many people thought COVID-19 would dissipate in 2021 as the vaccine is rolled out, but delays in administration of the vaccine mean that testing will cont...

New Year's celebrations are likely to look a lot different this year than most, as many people heed warnings to steer clear of mass gatherings during the global COVID-19 pandemic. Wall Street also seems to have had some cold water thrown on what was otherwise an extremely strong year for th...

When reviewing the companies with the fastest growth in 2020, it immediately becomes clear that the COVID-19 pandemic is behind most of the changes that have propelled sales for diagnostics and remote-work companies. Fulgent Genetics (NASDAQ: FLGT) and Zoom Video Commu...

Fulgent Genetics (FLGT) extended its partnership with the New York City Department of Education and NYC Health + Hospitals for COVID-19 testing through the remainder of the 2021 school year.Under the agreement, Fulgent will provide COVID-19 testing for students and employees at many K-12...

TEMPLE CITY, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq: FLGT), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that the Company has extended its partnership with the New York City Departme...

Shares of Fulgent Genetics (NASDAQ: FLGT) have been hovering near their all-time high after a big jump this summer. After rising around 231% year to date, can this coronavirus stock put up additional big gains for investors? The relatively young diagnostics company owes its rece...

RALEIGH, N.C., Dec. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing capabilities. Enabled through a collaboration with PWNHealth and Fulgent Genetics (NASDAQ: FLG...

When Snowflake went public in September, the investment community was abuzz. The cloud-data warehousing company had astounding growth, proven leadership, and a world of traders clamoring for shares. The stock more than doubled on the first day of trading and hasn't looked back. ...

If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ: FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. That is a stunning performance considering the S&P 500 index only returned 14.5% during the same ...

The pandemic changed the fortunes of a lot of healthcare stocks in 2020. Little-known biotechs and diagnostics companies struggling for survival suddenly found themselves with customers, funding, and stock prices like they had never imagined. The stock of Fulgent Genetics (NAS...